Research & Development
Philippines purchases 25 million doses of China's Sinovac's COVID-19 vaccine
11 January 2021 -

A government official of the Philippines said on 1 January 2021 that the Philippines has secured 25 million doses of COVID-19 vaccines developed by China's Sinovac Biotech, Reuters news agency reported on Monday.

The first 50,000 doses of this COVID-19 vaccine are expected to arrive in February 2021.

Presidential Spokesman, Harry Roque, was quoted as saying that the rest of the Sinovac vaccines will arrive in batches from March until December 2021.

Carlito Galvez, a former general in charge of the vaccination procurement effort, told a senate inquiry that the Phillipines government hopes to vaccinate 50,000 people next month with priority to healthcare workers.

According to Reuters, some senators have expressed concern over delays in the rollout of COVID-19 vaccines, as compared with regional peers, while the government may have difficulties convincing the public of their safety, with a recent survey showing less than a third Filipinos were willing to get inoculated.

Galvez said negotiating with vaccine manufacturers was a "tedious" process and described the global vaccine supply as "very volatile".

The Philippine Food and Drug Administration (FDA) has yet to approve any COVID-19 vaccines and emergency use authorisation applications filed by Pfizer, AstraZeneca and Russia's Gamaleya are pending.

The FDA is still evaluating the late-stage trial applications of Sinovac and Clover.

Also, the Philippine has secured 30 million doses of the vaccine Covovax from Serum Institute of India and expects to receive 40 million doses through the COVAX facility in the first quarter of 2021.



Related Headlines